Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

Vicente García-Patos Briones, Ramón M Pujol Vallverdú, Pere Soler-Palacín, Roger Colobrán Oriol, Andrea Martín-Nalda, Claudia Fortuny Guasch, Lourdes Rey, Tom D. Bunney, Laia Alsina Manrique, Ana Esteve-Solé, Daniel Bull, Maria Carmen Anton, Maria Basagaña, Ferran Casals, Ángela Deyà-Martínez, Marina Garcia-Prat, Ramon Gimeno, Manel Juan, Helios Martinez-Banaclocha, Juan J. Martinez-GarciaAnna Mensa-Vilaró, Raquel Rabionet, Nieves Martin-Begue, Francesc Rudilla, Xavier Estivill, Matilda Katan, Pablo Pelegrín, Asun Vicente, Juan Ignacio Aróstegui

Research output: Contribution to journalArticleResearchpeer-review

30 Citations (Scopus)

Abstract

The online version of this article (10.1007/s10875-020-00794-7) contains supplementary material, which is available to authorized users.
Original languageEnglish
Pages (from-to)987-1000
Number of pages14
JournalJournal of Clinical Immunology
Volume40
DOIs
Publication statusPublished - 2020

Keywords

  • Autoinflammatory diseases
  • APLAID
  • PLCγ2
  • Inflammasome
  • Caspase-1
  • Interleukin-1
  • Agammaglobulinemia

Fingerprint

Dive into the research topics of 'Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations'. Together they form a unique fingerprint.

Cite this